Sweden· SE-20080128000070
INVEGA 1,5 mg Depottablett
A medicinal product containing paliperidone, registered in Sweden by Janssen-Cilag International NV.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Paliperidone
- Manufacturer
- Janssen-Cilag International NV
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- August 27, 2026
Packs & prices · 1
- se_varunummer20080128000070
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Paliperidone in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesINVEGAJanssen Pharmaceuticals, Inc.
- BelgiumInvega 1.5 mgJanssen-Cilag International
- FinlandInvegaJanssen-Cilag International NV
- NetherlandsInvega 1,5 mg, tabletten met verlengde afgifteJanssen-Cilag International NV
- CzechiaBYANNLIJanssen-Cilag International N.V., Beerse
- SpainBACEQ 100 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EFGTeva Pharma S.L.U.
- PolandBYANNLIJanssen-Cilag International N.V.
- IcelandBYANNLIJanssen-Cilag International NV*
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Denepra, Palibon
- Belgium · Paliperidon Eg, Paliperidon Krka
- Bulgaria · Егоропал, Палиперидон Тева
- Cyprus · Paliperidon Tad, Paliperidone Palmitate Stada
- Czechia · Balení Pro Zahájení Lécby Psylipax, Dvezlarq
- Germany · Paliperidon 1 A Pharma, Paliperidon Abz
- Denmark · Dopelir, Egoropal
- Estonia · Mopetia, Paliperidone Sandoz
- Spain · Baceq, Dvezlarq
- Finland · Lodixeon, Paliperidon Ratiopharm
- France · Paliperidone Bgr, Paliperidone Biogaran
- United Kingdom (Northern Ireland) · Paliperidone Mylan, Paliperidone Neuraxpharm Uk
- Greece · Dopelir, Paliperidone Palmitate Stada
- Croatia · Arion, Dvezlarq
- Hungary · Egoropal, Paliperidon Actavis
- Ireland · Paliperidone Clonmel, Paliperidone Krka
- Iceland · Byannli, Invega
- Italy · Palbran, Paliperidone Eg
- Liechtenstein · Byannli, Invega
- Lithuania · Paliperidone Sandoz, Paliperidone Teva
- Luxembourg · Paliperidon Ratiopharm, Paliperidone Eg
- Latvia · Mopetia, Paliperidone Sandoz
- Malta · Paliperidone Clonmel
- Netherlands · Paliperidon Cf, Paliperidon Krka
- Norway · Byannli, Invega
- Poland · Dvezlarq, Egoropal
- Portugal · Aldesven, Fredexel
- Romania · Mopetia, Paliperidonă Stada
- Slovenia · Paliperidon Teva, Paliperidon Vale
- Slovakia · Egoropal, Paliperidón Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52823224-bf59-4f2c-9deb-5fdc7d7bf3e0 GET /v1/drugs/52823224-bf59-4f2c-9deb-5fdc7d7bf3e0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20080128000070",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20080128000070",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/invega-epar-product-information_sv.pdf"
}See everything about paliperidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.